These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34401966)

  • 21. Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets.
    Azmi NHS; Ming LC; Uddin ABMH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2022; 26(1):80-87. PubMed ID: 35081048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
    Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
    Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Texture Analysis Technique in Formulation Development of Lyophilized Orally Disintegrating Tablets Containing Mannitol, Polyvinylpyrrolidone and Amino Acids.
    Hackl E; Ermolina I
    AAPS PharmSciTech; 2019 Jan; 20(2):71. PubMed ID: 30631978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
    Nakamura S; Fukai T; Sakamoto T
    AAPS PharmSciTech; 2021 Dec; 23(1):37. PubMed ID: 34950985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.
    Koner JS; Rajabi-Siahboomi AR; Missaghi S; Kirby D; Perrie Y; Ahmed J; Mohammed AR
    Sci Rep; 2019 Aug; 9(1):12467. PubMed ID: 31462654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS; Aboul-Einien MH
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Tablet-in-Syringe': A Novel Dosing Mechanism for Dysphagic Patients Containing Fast-Disintegrating Tablets Fabricated Using Semisolid Extrusion 3D Printing.
    Panraksa P; Zhang B; Rachtanapun P; Jantanasakulwong K; Qi S; Jantrawut P
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent.
    Late SG; Banga AK
    AAPS PharmSciTech; 2010 Dec; 11(4):1627-35. PubMed ID: 21086083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A generalized image analytical algorithm for investigating tablet disintegration.
    Wu JX; Balantic E; van den Berg F; Rantanen J; Nissen B; Friderichsen AV
    Int J Pharm; 2022 Jul; 623():121847. PubMed ID: 35643346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the effect of processing parameters on pharmaceutical tablet disintegration using a real-time particle imaging approach.
    Rajkumar AD; Reynolds GK; Wilson D; Wren S; Hounslow MJ; Salman AD
    Eur J Pharm Biopharm; 2016 Sep; 106():88-96. PubMed ID: 27287552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of formulation and manufacturing process parameters on the characteristics of lyophilized orally disintegrating tablets.
    Jones RJ; Rajabi-Siahboomi A; Levina M; Perrie Y; Mohammed AR
    Pharmaceutics; 2011 Jul; 3(3):440-57. PubMed ID: 24310589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.
    Lund K; Kito H; Skydtsgaard MB; Nakazawa H; Ohashi-Doi K; Lawton S
    Clin Ther; 2019 Apr; 41(4):742-753. PubMed ID: 30885398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation.
    Draksiene G; Venclovaite B; Pudziuvelyte L; Ivanauskas L; Marksa M; Bernatoniene J
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34203634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of non-water-soluble placebo pellets of different sizes on the characteristics of orally disintegrating tablets manufactured by freeze-drying.
    Stange U; Führling C; Gieseler H
    J Pharm Sci; 2013 Jun; 102(6):1786-1799. PubMed ID: 23568590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
    Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of mathematical model to predict disintegration time of fast disintegrating tablets using powder characteristics.
    Goel H; Arora A; Tiwary AK; Rana V
    Pharm Dev Technol; 2011 Feb; 16(1):57-64. PubMed ID: 20028210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.
    Xu X; Gupta A; Sayeed VA; Khan MA
    J Pharm Sci; 2013 May; 102(5):1513-23. PubMed ID: 23450666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.